BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11433220)

  • 1. How recombinant insulin analogs improve insulin therapy of diabetes mellitus: pathophysiology, clinical practice and recommendations.
    Tatoń J; Milicevic Z; Mozejko-Pastewka B; Bernas M; Czech A
    Med Sci Monit; 2001; 7(4):848-59. PubMed ID: 11433220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
    Marbury TC; Schwartz S; Rosenberg MA; Jariwala N; Becker RH; Johnston PS
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-acting insulin analogs: progressing slowly].
    Holleman F; Hoekstra JB
    Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1668-9. PubMed ID: 15453117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
    Yki-Järvinen H
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study.
    Fischer JS; McLaughlin T; Loza L; Beauchamp R; Schwartz S; Kipnes M
    Curr Med Res Opin; 2004 Nov; 20(11):1703-10. PubMed ID: 15537471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin aspart: a review.
    Owens D; Vora J
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):793-804. PubMed ID: 17014395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does insulin detemir have a role in reducing risk of insulin-associated weight gain?
    Hermansen K; Davies M
    Diabetes Obes Metab; 2007 May; 9(3):209-17. PubMed ID: 17391147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoglycemia in type 1 diabetes: a still unresolved problem in the era of insulin analogs and pump therapy.
    Shalitin S; Phillip M
    Diabetes Care; 2008 Feb; 31 Suppl 2():S121-4. PubMed ID: 18227471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: Chinese PRESENT study.
    Gao Y; Guo XH; Vaz JA;
    Diabetes Obes Metab; 2009 Jan; 11(1):33-40. PubMed ID: 18494806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
    Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of highly purified Iletin-II-type porcine insulins and human insulin preparations in clinical practice].
    Petunina NA; Balabolkin MI; Mkrtumian AM; Sergeev AV; Nedosugova LV
    Ter Arkh; 1993; 65(10):29-31. PubMed ID: 8296229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining effective insulin analog therapy based on the individualized needs of patients with type 2 diabetes mellitus.
    Gong WC
    Pharmacotherapy; 2008 Oct; 28(10):1299-308. PubMed ID: 18823224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of children and adolescents with diabetes mellitus: personal experience].
    Dorchy H
    Rev Med Brux; 2005 Sep; 26(4):S246-54. PubMed ID: 16240870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of insulin analogs.
    Brixner DI; McAdam-Marx C
    Am J Manag Care; 2008 Nov; 14(11):766-75. PubMed ID: 18999911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
    Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
    Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single-center, randomized, double-blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus.
    Schwartz S; Zagar AJ; Althouse SK; Pinaire JA; Holcombe JH
    Clin Ther; 2006 Oct; 28(10):1649-57. PubMed ID: 17157120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiation of insulin glargine in children and adolescents with type 1 diabetes.
    Tan CY; Wilson DM; Buckingham B
    Pediatr Diabetes; 2004 Jun; 5(2):80-6. PubMed ID: 15189493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin therapy for maximal glycemic control in type 2 diabetes mellitus.
    Spellman CW
    J Am Osteopath Assoc; 2007 Jul; 107(7):260-9. PubMed ID: 17682113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin analogs. More precise control for diabetic patients is possible].
    MMW Fortschr Med; 2001 Jan; 143(3):52-3. PubMed ID: 11215346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.